Nationwide Fund Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,229,700
Closed -$78.4M 287
2017
Q3
$78.4M Buy
1,229,700
+151,695
+14% +$8.86M 0.31% 39
2017
Q2
$60.1M Sell
1,078,005
-16,484
-2% -$897K 0.24% 53
2017
Q1
$59.5M Sell
1,094,489
-53,496
-5% -$2.93M 0.24% 53
2016
Q4
$67.1M Sell
1,147,985
-191,996
-14% -$10.5M 0.28% 45
2016
Q3
$72.3M Sell
1,339,981
-348,891
-21% -$22.4M 0.3% 41
2016
Q2
$124M Buy
1,688,872
+400,702
+31% +$28.3M 0.54% 21
2016
Q1
$80.8M Sell
1,288,170
-122,876
-9% -$7.75M 0.35% 34
2015
Q4
$97.1M Sell
1,411,046
-294,720
-17% -$19.5M 0.42% 31
2015
Q3
$101M Buy
1,705,766
+45,215
+3% +$2.87M 0.45% 26
2015
Q2
$110M Buy
1,660,551
+84,642
+5% +$5.58M 0.45% 27
2015
Q1
$102M Buy
1,575,909
+175,360
+13% +$11M 0.41% 29
2014
Q4
$82.7M Sell
1,400,549
-36,046
-3% -$2.03M 0.35% 36
2014
Q3
$73.5M Sell
1,436,595
-205,740
-13% -$10.3M 0.31% 44
2014
Q2
$79.7M Sell
1,642,335
-1,528
-0.1% -$75.3K 0.32% 37
2014
Q1
$85.4M Sell
1,643,863
-187,133
-10% -$9.96M 0.39% 33
2013
Q4
$97.3M Buy
1,830,996
+74,014
+4% +$3.77M 0.4% 27
2013
Q3
$81.3M Buy
1,756,982
+116,575
+7% +$5.12M 0.37% 33
2013
Q2
$73.3M Buy
+1,640,407
New +$71.2M 0.39% 36

Other funds holding BMY

Nationwide Fund Advisors's BMY Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 1,229,700 shares — an estimated $78.4M sold.

Nationwide Fund Advisors first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $124M in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,229,700 Bristol-Myers Squibb shares in Q4 2017, an estimated $78.4M.
  • Nationwide Fund Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Bristol-Myers Squibb position peaked at $124M in Q2 2016.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.